The combined treatment of BBB opening via FUS and GAS alleviates neuropathology of the AD-like mice by reducing the content of Aβ in the targeted hippocampus and attenuating the level of tau as well as P-tau in the same region. Here, MAPT is linked to Alzheimer disease.